#MonogenicDiabetes
MODY is prevalent in later onset diabetes. Really proud to announce the release of a preprint of our paper assessing MODY in people diagnosed with diabetes later in life!!
#MonogenicDiabetes
MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify https://www.medrxiv.org/content/10.1101/2025.06.17.25329143v1
June 19, 2025 at 12:05 PM
Excited to announce the acceptance and publication of our paper titled “Population prevalence, penetrants, and mortality for genetically confirmed MODY” in JCEM: doi.org/10.1210/clin...
#MODY #monogenicdiabetes
Population prevalence, penetrance, and mortality for genetically confirmed MODY
AbstractContext. Diagnosing Maturity-Onset Diabetes of the Young (MODY) is clinically important for treatment and prognosis. However, phenotype-based studi
doi.org
November 3, 2025 at 11:02 AM
Global perspectives on #MonogenicDiabetes: review explores recent advances, global diagnostic challenges and promising future directions—from genomic equity to innovative therapies. #GlobalHealth link.springer.com/article/10.1... 🔓
Global perspectives on monogenic forms of diabetes - Diabetologia
Monogenic forms of diabetes represent an uncommon but very heterogeneous subset of the disease, with variable associated clinical features and key differences in treatment options. In this review, we ...
link.springer.com
July 22, 2025 at 5:35 PM
Fantastic talk by Dr. Aisha Ansar on monogenic diabetes. GCK-MODY causes mild, stable hyperglycemia with preserved C-peptide, negative antibodies, and low complication risk—critical to recognize when evaluating patients with atypical diabetes.
#MonogenicDiabetes #MODY @washumedicine.bsky.social
January 23, 2026 at 1:23 AM